McKesson
MCKMarket price data through July 31, 2026.
Performance
Aug 2021 – Jul 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- +68%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$509
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- September 2024
- The month this stock first became a Benson pick.
- Tracking duration
- 22 months
- How long Benson has been tracking this pick.
About McKesson
McKesson is the company that gets medicine from drug makers to your local pharmacy, hospital, and cancer clinic. They run the delivery system that keeps prescriptions flowing across America, moving over 403 billion dollars worth of drugs and healthcare products every year.
The case for and against
Both sides of the story, in plain English.
- Blockbuster Year
McKesson just wrapped up a record fiscal year with revenue jumping 12% to 403 billion dollars and adjusted earnings per share climbing 18%, beating their own long-term targets. They are guiding for another 12% to 14% earnings growth next year, showing the momentum is not slowing down.
- Cancer Cash Machine
Their Oncology and Multispecialty business is the new growth engine, with revenue rocketing 35% last quarter and operating profit jumping 53%. As cancer treatment shifts to community clinics and specialty drugs explode in popularity, McKesson is right at the center of it.
- Razor Thin Margins
Even with 403 billion dollars flowing through the business, McKesson keeps just over 1 cent of profit on every dollar of revenue. That means any small disruption, contract renegotiation, or pricing pressure can hit the bottom line hard.
- Big Breakup
McKesson is splitting off its Medical-Surgical Solutions business and just sold a 13% stake to Apollo Global, while also exiting Europe entirely. These moves should sharpen focus on high-growth areas, but big corporate breakups always carry execution risk and short-term distraction.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-07-31. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch MCK for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.
Download on the App Store
Download Android app